Related Experiment Video

Updated: Jun 2, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

[Glycated hemoglobin (HbA1c) as a standard diagnostic criterium for diabetes?]

Marta Ewa Bryśkiewicz1, Lilianna Majkowska

  • 1Klinika Diabetologii i Chorób Wewnetrznych, Pomorski Uniwersytet Medyczny, Szczecin, Polska. pechmar@poczta.onet.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|May 7, 2011
PubMed

Insights

Glycated hemoglobin (HbA1c) is crucial for diabetes monitoring and diagnosis. However, method standardization is vital due to discrepancies impacting diabetes diagnosis rates.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Diabetes Mellitus Research

Background:

  • Glycated hemoglobin (HbA1c) is the gold standard for diabetes management and risk assessment.
  • Major studies like DCCT and UKPDS established HbA1c as an independent predictor of diabetic vascular complications.
  • The American Diabetes Association recommended HbA1c for diabetes diagnosis in 2010 due to its accuracy and stability.

Purpose of the Study:

  • To highlight the importance of HbA1c in diabetes assessment.
  • To discuss the challenges and necessity of standardizing HbA1c measurement methods.
  • To address discrepancies between HbA1c and glucose-based diagnoses.

Main Methods:

  • Review of HbA1c analytical methods including HPLC, affinity chromatography, electrophoresis, and immunoassays.
  • Comparison of HbA1c results obtained from different laboratory methods.
  • Analysis of discrepancies in carbohydrate disorder diagnosis based on HbA1c versus glucose levels.

Main Results:

  • HbA1c is widely used for routine diabetes monitoring and diagnosis.
  • Significant variations exist in HbA1c results depending on the analytical method employed.
  • Standardization of HbA1c methods is crucial for consistent and reliable clinical interpretation.
  • Discrepancies between HbA1c and glucose-based diagnoses raise concerns about widespread HbA1c adoption.

Conclusions:

  • Standardization of HbA1c measurement methods is essential for accurate diabetes diagnosis and management.
  • Addressing analytical variability is critical to ensure reliable risk assessment and treatment monitoring.
  • Further investigation is needed to reconcile diagnostic differences between HbA1c and glucose-based criteria.

More Related Videos

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...